SINTRONICS GmbH donates

This year, the company SINTRONICS GmbH from Schöneck has once again made a great donation to us. With 3,000 Euros they support the important research work in the field of cancer in children and adolescents.

A big thank you for this great commitment.
Dr. Constanze Schneider received the award for her scientific work on “SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia”, which was published in the journal “Nature Medicine”.

Until now, in acute myeloid leukaemia (AML) it was not possible to predict which patients would respond to standard chemotherapy with cytarabine. With SAMHD1, a new biomarker was discovered that can be used to identify patients who respond to chemotherapy with a high degree of accuracy.